Takaaki Maekawa

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Sequential Analysis of Murine Myelofibrosis Models Using a Novel Deep Learning-Based Fibrosis Quantitative Method.

Sequential Analysis of Murine Myelofibrosis Models Using a Novel Deep Learning-Based Fibrosis Quantitative Method.

Journal: EJHaem

Published: January 29, 2026

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.

Journal: International journal of hematology

Published: October 02, 2025

Role of Chitinase 3-like-1 in Myelofibrosis via Fibroblast-Produced Extracellular Matrix Enhancement.

Role of Chitinase 3-like-1 in Myelofibrosis via Fibroblast-Produced Extracellular Matrix Enhancement.

Journal: Journal of cellular physiology

Published: September 23, 2025

Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemia.

Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemia.

Journal: Annals of hematology

Published: November 08, 2024

Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.

Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.

Journal: Annals of hematology

Published: August 19, 2023

Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model.

Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model.

Journal: Blood cancer journal

Published: March 17, 2023

The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis.

The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis.

Journal: Acta haematologica

Published: August 24, 2021

Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study

Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 07, 2020

The role of fibrocytes in myelofibrosis and fibrocyte regulation as a novel treatment approach

The role of fibrocytes in myelofibrosis and fibrocyte regulation as a novel treatment approach

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 06, 2020

VEGF secretion from Epstein-Barr virus-infected cells as a cause of severe anasarca in a patient with angioimmunoblastic T-cell lymphoma

VEGF secretion from Epstein-Barr virus-infected cells as a cause of severe anasarca in a patient with angioimmunoblastic T-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 07, 2020

Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain.

Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain.

Journal: PloS one

Published: September 12, 2019

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Journal: Blood

Published: February 07, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026